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Abstract 
Sperm DNA damage has a negative impact on pregnancy rates following assisted reproduction 
treatment. The aim of the present study was to examine the relationship between sperm DNA 
fragmentation and live-birth rates after IVF and intracytoplasmic sperm injection (ICSI). The 
alkaline Comet assay was employed to measure sperm DNA fragmentation in native semen and in 
spermatozoa following density-gradient centrifugation in semen samples from 203 couples 
undergoing IVF and 136 couples undergoing ICSI. Men were divided into groups according to 
sperm DNA damage. Following IVF, couples with <25% sperm DNA fragmentation had a live-
birth rate of 33%; in contrast, couples with <50% sperm DNA fragmentation had a much lower 
live-birth rate of 13%. Following ICSI, no significant differences in sperm DNA damage were 
found between any groups of patients. Sperm DNA damage was also associated with low live-
birth rates following IVF in both men and couples with idiopathic infertility: 39% of couples and 
41% of men with idiopathic infertility have high sperm DNA damage. Sperm DNA damage 
assessed by the Comet assay has a close inverse relationship with live-birth rates after IVF. 
Keywords: Comet assay, ICSI, IVF, male infertility, sperm DNA damage 
Introduction 
Infertility affects ~15% of couples of reproductive age (Cates et al., 1985; Hull et al., 1985; Kols 
and Nguyen, 1997; Rutstein and Shah, 2004) with male infertility contributing to nearly 50% of all 
cases (Irvine, 1998; Niederberger et al., 2007; Vela et al., 2009; World Health Organization, 
2010). As a result of population ageing and adverse changes in lifestyle, infertility continues to 
increase but with only marginal improvement in pregnancy and birth rates after assisted 
reproduction treatment in the developed world (de Mouzon et al., 2010; Dupas and Christine-
Maitre, 2008; HFEA, 2008; Povey AC and Stocks, 2010). In the last 30 years, assisted 
reproduction treatment has become increasingly utilized, with the number of cycles (de Mouzon et 
al., 2010) increasing by 4% per year in Europe. Still, pregnancy and live-birth rates remain 
disappointedly low (average 27–33%; de Mouzon et al., 2010; HFEA, 2008). One reason for this 
is that little has been done to resolve the causes and potential therapies for male infertility at the 
molecular level. Furthermore, there are currently no routine pharmaceutical therapies for male 
infertility. 
Sperm DNA damage has been identified as a major contributor to male infertility as well as 
outcomes following assisted reproduction treatment, including impaired embryo development, 
miscarriage and birth defects in the offspring (Evenson et al., 1980, 1999; Balasuriya et al., 2011; 
Bungum et al., 2011; Ebner et al. 2011; Freour et al., 2010; Gu et al., 2011; Koskimies et al., 
  
2010; Simon et al., 2011; Zribi et al., 2011). There are a number of assays available to detect 
sperm DNA damage (see the ESHRE position paper by Barratt et al., 2010). The Comet assay is 
becoming a popular method to determine sperm DNA damage. It is recognized as the most 
sensitive of all methods and routinely used to assess genotoxic DNA damage in somatic cells 
(Decordier et al., 2010; Dhawan et al., 2009; Jha 2008; Pfuhler et al., 2005). It is the only 
technique that allows quantification of DNA damage in individual cells, so it is particularly useful 
in a heterogeneous cell population like spermatozoa. The Comet assay measures both single- and 
double-strand breaks using an alkaline pH method (Collins et al., 2008; Villani et al., 2010). 
The present study employed the alkaline Comet assay to examine sperm DNA damage in patients 
undergoing IVF and intracytoplasmic sperm injection (ICSI). The relationship between sperm 
DNA fragmentation and pregnancy, miscarriage and live-birth rates was examined. The second 
objective of this study was to assess the incidence of sperm DNA damage in couples and male 
partners with idiopathic infertility and determine if there was a relationship between their 
diagnosis and their treatment outcomes. Thirdly, this study determined the repeatability of the 
alkaline Comet assay by comparing data from three or two replicate slides for the same patient. 
Materials and methods 
This project was approved by the Office for Research Ethics Committees in Northern Ireland and 
the Royal Group of Hospitals Trust Clinical Governance Committee (ref. no. 06/NIR01/142, 9 
January 2007). The study was conducted at the Regional Fertility Centre, Royal Jubilee Maternity 
Services, Belfast, Northern Ireland, UK. Sperm samples for research were obtained after written 
consent given by each couple. 
Study population 
A total of 203 couples undergoing IVF (age 35.6   0.3 years, mean ± standard error) and 136 
couples undergoing ICSI (age 34.9 ± 0.4 years) were recruited in the study after a minimum of 1 
year of unprotected intercourse without pregnancy. 
Of the 203 men undergoing IVF, a subset was identified as the unexplained group (n = 147), 
which consisted of those remaining after the exclusion of men diagnosed with infertility according 
to criteria from the World Health Organization (2010; low sperm count, reduction in motility and 
normal morphology) or with a known history of fertility problems including blockages, testicular 
cancer or abnormal development of reproductive organs. For couples with idiopathic infertility (n 
= 70), those with women with endometriosis, ovulation dysfunction, hormone imbalance, ovarian 
cysts or tumours were also excluded. 
Semen analysis and sperm preparation 
Semen samples were provided by masturbation by the male partner after 2–5 days of 
recommended abstinence. After liquefaction, routine semen analyses were performed according to 
guidelines from the World Health Organization (2010) and subsequently semen was prepared 
using a two-step discontinuous Puresperm gradient (90–45%; Hunter Scientific, UK). Two 
populations of spermatozoa for each patient were used to measure DNA damage by Comet assay: 
the whole population (native semen) and those prepared by density-gradient centrifugation, typical 
of those used for clinical treatment. 
Assisted reproduction treatment 
All IVF cycles were performed according to routine procedures (Donnelly et al., 1998). Briefly, 
ovulation induction was achieved with recombinant FSH following a long protocol of pituitary 
desensitization with a gonadotrophin-releasing hormone analogue. Human chorionic 
gonadotrophin was administered when there were at least four follicles of >17 mm diameter, 36 h 
before oocyte retrieval. Mature, metaphase-II oocytes were obtained by vaginal ultrasound-guided 
  
aspiration and cultured in media (G5 sequential media series; Vitrolife, Goteborg, Sweden) at 37 C 
with 6% CO2 in air. The ICSI procedure has been described in detail previously (Van Steirteghem, 
et al., 1993). In brief, a suspension of washed spermatozoa was placed in polyvinylpyrrolidone 
(Vitrolife) and a free, motile spermatozoon was immobilized. The spermatozoon was aspirated 
into the injection pipette tail-first and injected into an oocyte. Fertilization was recorded 12–16 h 
after injection. In each case, one or two embryos were transferred into the uterine cavity after an 
additional 24–48 h. Luteal-phase support was provided by vaginally administered progesterone. 
An intrauterine pregnancy with fetal heart beat was confirmed by ultrasound 5 weeks after embryo 
transfer. 
Alkaline Comet assay 
Sperm DNA fragmentation was assessed using single-cell gel electrophoresis (Comet) assay which 
has been previously optimized for human spermatozoa (Donnelly et al., 1999; Hughes et al., 
1997). Briefly, fully frosted slides were covered with 150  l of 1% normal-melting-point agarose 
and left to solidify for 15 min at room temperature. Sperm samples were diluted to a final 
concentration 2   106 cells/ml with phosphate-buffered saline and 10 l cell suspension were 
mixed with 75 l of 0.5% low-melting-point agarose and placed on slides. After 15 min, slides 
were immersed in cold lysis solution (2.5 mol/l NaCl, 10 mmol/l Na2EDTA, 10 mmol/l Tris and 
1% Triton X-100) and incubated for 1 h. Following lysis, slides were incubated with 10 mmol/l 
dithiothreitol for 30 min at 4 C followed by incubation with 4 mmol/l lithium diiodosalicylate for 
90 min at room temperature. Slides were incubated in cold electrophoresis buffer (300 mmol/l 
NaON, 1 mmol/l EDTA, pH 13) for 20 min to allow DNA to unwind. Electrophoresis was carried 
out at 25 V, 300 mA for 10 min. Slides were flooded with three changes of neutralization buffer 
(0.4M Tris) for 5 min. Slides were stained with 20 g/ml ethidium bromide and visualized using 
Komet version 5.5 (Andor Technology, Belfast, UK). Fifty comets were analysed for each slide. 
Statistical analysis 
Since some of the groups contained a small number of patients, residuals were tested with 
Statistical Package for the Social Sciences for Windows version 15 (SPSS, Chicago, IL, USA) to 
assure normality of distribution so that t-testing was appropriate. Having confirmed that residuals 
followed a normal distribution, P-values were calculated using an unpaired two-tailed t-test 
(GraphPad Prism for Windows version 5.01; GraphPad Software, San Diego, California, USA). 
Data are presented as mean ± standard error. 
The chi-squared test was used to assess whether there was a linear trend between the level of 
sperm DNA damage and pregnancy or live-birth rates in IVF and ICSI patients as well as men and 
couples with idiopathic infertility. Pregnancy and live-birth rates were organized in the frequency 
tables according to the level of sperm DNA damage and chi-squared and P-values were obtained 
for each analysis. 
Repeatability assessment 
Analysis of repeatability was performed according to the guidelines of ISO 5725 (1994) to 
determine the repeatability and reproducibility of a standard measurement method. Fifty-two 
patient samples were prepared in duplicate (28/52) or in triplicate (24/52) (128 measurements in 
total). Five comets were scored on 10 different areas of each slide (50 comets per slide). Data from 
50 comets for each measurement were used to calculate means and standard errors. Residual 
values were calculated to identify and remove outliers using Dixon’s test. The test statistic r22 was 
calculated using the equation  and compared with the critical value for r22 at a 
significance level of 0.05. The repeatability (r) was defined as , where  is the 
repeatability variance or average of the within-laboratory variances and calculated as 
  
. The values were calculated separately for duplicate and triplicate 
measurements based on 75 degrees of freedom. 
Results 
Demographic characteristics of patients undergoing IVF 
Patients receiving IVF were divided in three groups according to the treatment outcome: (i) 
clinical pregnancy that resulted in miscarriage; (ii) clinical pregnancy that resulted in a live birth; 
and (iii) a nonpregnant group. Each group was compared with the live-birth group and confidence 
intervals and P-values were calculated for each comparison. 
When the miscarriage group was compared with the live-birth group, the only parameter that 
differed significantly was the total embryo cumulative score (Table 1). Between nonpregnant 
couples and the live-birth groups, there were significant differences in female age (35.9 ± 0.3 
versus 34.5 ± 0.7 years, P = 0.04), male age (37.5 ± 0.4 versus 35.5 ± 0.9 years, P = 0.02), 
transferred embryo cumulative score (35.8 ± 1.7 versus 43.0 ± 2.7, P = 0.01) and the number of 
fertilized oocytes (4.4 ± 0.3 versus 6.9 ± 0.6, P < 0.0001). 
Demographic characteristics of patients undergoing ICSI 
Patients undergoing ICSI were divided into three groups similarly to those undergoing IVF (Table 
2) and each group was compared with the live-birth group. No statistically significant difference 
was detected between the miscarriage and live-birth groups in any parameters studied. However, 
there was a significant decrease in number of fertilized oocytes in nonpregnant couples compared 
with the live-birth group (4.9 ± 0.3 versus 6.1 ± 0.6, P = 0.04). 
Sperm DNA fragmentation and treatment outcomes following IVF and ICSI 
The level of sperm DNA damage was significantly higher for groups undergoing IVF in the 
nonpregnant group compared with the live-birth group both in terms of native semen and those 
prepared by density-gradient centrifugation (P < 0.01 and P < 0.05, respectively, Figure 1). In 
contrast, no significant difference was found in DNA damage between any of the groups 
undergoing ICSI in both native and prepared spermatozoa (Figure 1). 
Patients undergoing IVF were divided into three groups depending on the level of sperm DNA 
damage (0–25%, 25–50% and over 50%) in accordance with previously reported clinical 
thresholds for achieving successful pregnancy after natural conception, IVF and ICSI, respectively 
(Simon et al., 2011). This previous study reported that if men had <25% sperm DNA damage, they 
were more likely able to achieve a pregnancy without assisted reproduction treatment. If the men 
had 25–50% sperm DNA damage, their chances of success following IVF were high. However, if 
the men had >50% sperm DNA damage, their best chance of success was with ICSI. The 
proportions of pregnant couples, couples with miscarriages and couples whose pregnancies 
resulted in live birth were also calculated for each group (Table 3). The highest proportion of 
pregnant couples (39.4%) was recorded in the group of patients with <25% sperm DNA damage. 
More importantly, 11 out of the 13 pregnancies in this group of patients (33.3% of the whole IVF 
group) resulted in live birth. When the sperm DNA fragmentation threshold was increased to 25–
50%, the proportions of pregnancies and live births declined to 29.6% and 23.9%, respectively. 
Statistically significant reductions in pregnancy rate (chi-squared = 8.05, P = 0.005) and live-birth 
rate (chi-squared = 7.20, P = 0.007) were also recorded in patients with >50% sperm DNA 
damage (16.2 and 13.1%, respectively). 
Analysis of pregnancy and live-birth rates in patients undergoing ICSI showed that there was no 
relationship between sperm DNA fragmentation and either pregnancies or live births (Table 3). 
  
Further, no relationship was found between sperm DNA damage and child gender or the number 
of singletons compared with twins (data not shown). 
Sperm DNA fragmentation in men with normal semen analysis (idiopathic 
infertility) 
To gain further insight into the relationship between different types of infertility and treatment 
outcomes, this study assessed DNA fragmentation levels in couples undergoing IVF according to 
diagnosis. Patients were divided into two groups depending on infertility diagnosis: (i) idiopathic 
men (couples with a diagnosed female factor but no detectable problems in the male partners); and 
(ii) idiopathic couples (no detectable male or female factors). Sperm DNA fragmentation was 
assessed in each group and related to pregnancy, miscarriage and live-birth rates. Sperm DNA 
damage in the idiopathic men group (n = 147) was 46.9 ± 1.8% in native semen and 32.8 ± 1.6% 
in prepared spermatozoa (Table 4). The overall pregnancy and live-birth rates in this patient group 
was 21.1% (31 out of 147 patients) and 17.0% (25 out of 147 couples), respectively (Table 5). 
Using 25% DNA damage as a cut off to predict successful pregnancies following IVF (Simon et 
al., 2011) 23 (15.6%) patients had <25% DNA damage in native semen. Sixty-four men (43.5%) 
had 25–50% DNA fragmentation while 60 men (40.8%) had >50% sperm DNA damage. The 
pregnancy rate for men with <25% sperm DNA fragmentation was 26.1%. All couples in this 
group had successful pregnancies. While a slight decrease in pregnancy rate was detected for the 
group of patients with 25–50% sperm DNA fragmentation (25.0%), the live-birth rate dropped 
markedly to 18.8%. The pregnancy rate in patients with >50% sperm DNA fragmentation was 
15.0% while the live-birth rate in this group was 11.7%. This was a more than 2-fold reduction 
compared with the live-birth rates in the <25% sperm DNA damage group. The chi-squared test, 
however, did not show statistical significance of the trend (chi-squared = 2.69). 
Sperm DNA fragmentation in couples diagnosed with idiopathic infertility 
The same analysis was performed for 70 couples with idiopathic infertility (no detectable cause of 
male or female infertility). The DNA damage levels in native and prepared spermatozoa did not 
differ significantly from that of the group of men with normal semen parameters and were 45.8 ± 
2.6 and 32.7 ± 2.4, respectively (Table 4). The same proportion of patients had <25% sperm DNA 
damage (15.7%) and 25–50% sperm DNA fragmentation (45.7%, Table 5). Slightly lower 
numbers of couples with idiopathic infertility (38.6%) had >50% sperm DNA damage compared 
with men with idiopathic infertility whose female partners had detectable causes. 
Lower overall pregnancy and live-birth rates were recorded in this group (20.0% and 14.3%, 
respectively). The pregnancy and live-birth rates in the group with <25% sperm DNA damage 
were both 27.3% (Table 5). The pregnancy rates for the other two groups of patients decreased to 
21.9% and 14.8% for 25–50% sperm DNA damage and >50% sperm DNA damage, respectively. 
Surprisingly low live-birth rates (12.5% and 11.1%) with a concomitant increase in miscarriage 
rates were recorded for both groups compared with patients with <25% sperm DNA 
fragmentation; however, the trend was not statistically significant (chi-squared = 1.24). 
Subdividing patients into subgroups with 50–60%, 60–70%, 70–80% and 80–90% sperm DNA 
damage showed a similar distribution pattern between the groups (data not shown). 
Repeatability of the Comet assay 
Repeatability refers to within-laboratory agreement between replicate observations of the same 
test performed by the same operator under similar conditions. Repeatability of Comet assay was 
assessed through comparison of duplicate or triplicate results from the same sample. One-way 
ANOVA was used to calculate variance. Based on this value, the standard errors of precision for 
single, duplicate and triplicate measurements were measured. To conduct the repeatability 
assessment of the alkaline Comet assay, DNA damage data was obtained from five random comets 
scored on 10 different areas on each slide (50 comets per slide ) on two or three replicate slides for 
  
all 52 samples. Data from 50 comets were used to calculate mean and standard deviation, which 
provided 128 means and 76 degrees of freedom. After plotting residual values for mean DNA 
damage, three potential outliers were detected in this dataset and Dixon’s test was used for 
identification and rejection of the outliers (Figure 2). One of them was classified as an outlier (P = 
0.05) after applying Dixon’s test and was excluded from further analysis, thus decreasing the 
degrees of freedom to 75. 
The value for a single DNA damage measurement was found to be 3.73% while it decreased 
to 2.65% and 2.16% for duplicates and triplicates, respectively. According to the standard error of 
precision, the likely range of the true value for a patient with 60% sperm DNA damage will be 
narrow, at 55.7–64.3%. 
Discussion 
Sperm quality is routinely assessed by measuring concentration, motility and morphology (World 
Health Organization, 2010). While conventional semen analysis can be useful as initial evaluation 
of a patient’s fertility status, there is growing evidence that it has limited value in diagnosing male 
infertility or predicting success of assisted reproduction (Berlinguer et al., 2009; Björndahl and 
Haugen, 2008; Ford, 2010; Garrido et al., 2008; Nagler, 2011; Saleh et al., 2003; Shamsi et al., 
2010). Although currently not in the battery of routine clinical tests offered to patients, sperm 
DNA damage has been demonstrated to be a promising tool in determining the male patient’s 
fertility status and to predict successful treatment in terms of the short-term goals of fertilization 
and pregnancy and the long-term goal of healthy offspring. 
No methods are currently available to measure DNA damage in spermatozoa that will be 
subsequently used clinically. However, of the methods currently available to determine sperm 
DNA damage, the Comet assay is considered the most sensitive (Irvine et al., 2000; Leroy et al., 
1996; Villani et al., 2010). It detects single- and double-strand breaks as well as abasic sites 
(Villani et al., 2010). It is the only test that quantifies DNA fragmentation in an individual 
spermatozoon. In addition, it requires a small number of cells, therefore making it suitable to 
assess DNA damage in semen samples supplied for routine analysis without the need of a further 
sample dedicated to DNA testing. Most importantly, robust clinical threshold values have now 
been established for this test (Simon et al., 2011). It has also been demonstrated to provide a 
stronger prognostic ability to predict fertilization after IVF than progressive motility (Simon and 
Lewis, 2011). Some have suggested that the low number of cells (50 spermatozoa in duplicate or 
triplicate) counted in the Comet assay gives it low repeatability. In order for it to be fully accepted 
by the clinicians and scientific community, there must be tight regulations on the protocol used. 
Furthermore, to be approved as a standard analytical tool in clinical laboratories, the Comet assay 
must be shown to have single laboratory validation, the process that includes optimization, 
standardization, establishing of thresholds, measuring diagnostic specificity and sensitivity and 
calculating repeatability and reproducibility. This study group has reported results for optimization 
and standardization of the Comet assay together with clinical thresholds, diagnostic specificity and 
sensitivity (Lewis and Simon, 2010; Simon et al., 2011). The current study evaluated within-
laboratory variance (repeatability) of the assay as recommended in ISO 5725 and found results 
highly repeatable and consistent between replicate slides. The standard error of precision for 
duplicate slides was found to be 2.65%. The greatest source of error in detecting tail DNA in the 
Comet assay is the electrophoresis step, in particular the drop in voltage across the gel (Collins et 
al., 2008). To account for that, the current study routinely analysed five comets on 10 different 
areas of the slide, thus increasing sample representativeness, and this was also reflected in 
extremely low variability between the duplicate or triplicate slides. 
This study observed a close negative relationship between nonpregnant and the live-birth groups 
in some parameters of treatment outcome, in particular total embryo cumulative score and 
transferred embryo score and a failure to achieve a pregnancy following IVF. This is consistent 
with previous reports from this study group (Simon et al., 2011) and others (Hu et al., 1998; Lee et 
al., 2006; Loi et al., 2008; Qian et al., 2008; Sjöblom et al., 2006). Both the total embryo 
  
cumulative score and transferred embryo cumulative score were considerably reduced in the 
nonpregnant group compared with patients having live births after IVF. In contrast, in ICSI 
patients, no relationship was detected in either total or transferred embryo cumulative score and 
live births. These results are in agreement with other studies that have shown a strong correlation 
between embryo quality (Avendaño et al., 2010; Meseguer et al., 2008) and sperm DNA 
fragmentation. 
There is a growing body of research showing a link between high sperm DNA damage and poor 
outcomes, including fertilization rate, pre- and post-implantation embryo development and 
implantation rate (Anendano and Oehninger, 2011; Host at al., 2000; Hu et al., 1998; Meseguer et 
al., 2008; Qian et al., 2008; Simon et al., 2011; Sjöblom et al., 2006). This has also been reported 
for the multiparous pig where the number of piglets per litter is reduced with higher sperm DNA 
damage (Ballachey et al., 1988). In another study where female pigs had proven fertility, the 
negative influence of sperm DNA damage on reduced pregnancy outcomes was also evident 
(Didion et al., 2009). 
The main focus of the present study was to determine, as far as is known for the first time using 
the Comet assay, if there was an association between levels of sperm DNA damage in male 
patients and live-birth rates following IVF and ICSI. As with this study group’s earlier results of 
total embryo cumulative score, transferred embryo cumulative score and number of oocytes 
fertilized (Simon et al., 2010), the inverse relationship between sperm DNA damage and outcome 
was consistent for both native semen and prepared spermatozoa. Furthermore, analysis of 
pregnancy rates and sperm DNA damage in IVF patients showed a strong negative relationship, 
with pregnancy rates declining from 39.4% in men with <25% sperm DNA damage to 16.2% in 
patients with >50% sperm DNA fragmentation. This, again, is well supported by this study group 
(Simon et al., 2011)and those of others (Bakos et al., 2008; Benchaib et al., 2007; Bungum et al., 
2007; Zini, 2011). 
A relationship between high sperm DNA fragmentation and male infertility is well documented in 
the literature (Evenson et al., 1980; Aitken and Curry, 2011; Mahfouz et al., 2010; Simon et al., 
2011). In the current study, the relationships between sperm DNA fragmentation and outcomes, 
including live-birth rates in couples with idiopathic infertility (all couples with either male and 
female factors were excluded) undergoing IVF, were also assessed. Elevated levels of sperm DNA 
damage in both native and prepared spermatozoa in comparison to the low levels of sperm DNA 
damage (12.47 ± 1.67%) reported in native spermatozoa of fertile donors (Simon et al., 2011) 
were found in the couples with idiopathic infertility. 
While overall pregnancy rates for IVF and ICSI were found in line with those reported recently for 
Europe (de Mouzon et al., 2010), they declined to 21% for both men and couples with idiopathic 
infertility. Since it is well recognized that pregnancy rates after IVF and ICSI are much lower 
compared with pregnancy rates after natural conception and need to be improved (Habbema et al., 
2009; Tam et al., 2005), a further reduction in pregnancy rates in groups of patients with 
idiopathic infertility is an unacceptable and worrying fact. Obviously, efforts should be 
concentrated on elucidating the causes of idiopathic infertility in order to prescribe appropriate and 
effective treatment for these patients. 
Of couples undergoing IVF, 72% of men and 34.5% had idiopathic infertility. Over 40% of men 
(60 out of 147) and nearly 39% of couples (27 out of 70) with idiopathic infertility had sperm 
DNA damage >50%. If these levels of damage are compared with those reported in spermatozoa 
of donor men with proven fertility by this study group (Simon et al., 2010), the current results 
suggest that sperm DNA damage is the cause of infertility in a substantial number of men. Another 
previous study (Simon et al., 2011) showed that 50% sperm DNA damage is the clinical threshold 
above which men are less likely to achieve a pregnancy by IVF. The live-birth rates are 
depressingly low (11.7% and 11.1%). Furthermore, if these couples or men are removed from the 
patients receiving IVF, the success rates in terms of pregnancies and live-birth rates will increase 
enormously; they would be expected to have high success rates since no anomalies can be 
detected. 
  
It is now clear that many men with normal semen parameters have high levels of sperm DNA 
damage. They are often mistakenly classified as having idiopathic infertility or even being fertile 
individuals which, in turn, can lead to offering intrauterine insemination or IVF to such couples 
with little chance of success. This fact is reflected in disappointedly low effectiveness of IVF, 
which is measured as the cumulative incidence of live delivery after commencing IVF (Stewart et 
al., 2011). 
Since many women will not return after a poor response to IVF, this value may overestimate the 
cumulative live-birth rate, so that the actual live-birth rates following IVF are even smaller. Yet, it 
falls to an unprecedented low of 11.7% and 11.1% in men and couples diagnosed with idiopathic 
infertility who have >50% sperm DNA damage, respectively. According to sperm DNA 
fragmentation analysis these patients should be directed straight to ICSI, thus avoiding loss of 
valuable biological time, cost of failed cycles and heartache after repeatedly unsuccessful cycles 
of IVF. This once again underscores the importance of DNA fragmentation analysis in guiding the 
patients to the appropriate treatment and necessity of including it in routine clinical testing 
(Bungum et al., 2007; Giwercman et al., 2009). 
In agreement with a previous report published by this study group (Simon et al., 2010), this study 
found that spermatozoa from patients having ICSI that did not result in clinical pregnancy tended 
to have a higher level of DNA fragmentation but this was not significantly greater than that of the 
live-birth group irrespective of type of spermatozoa (native or prepared) used in the assay. It has 
been reported in the literature that sperm DNA damage assessment may be less informative in 
patients undergoing ICSI since this technique bypasses all natural selection barriers such as 
binding to the zona pellucida, acrosomal reaction and fusion to the ooplasm, and therefore 
fertilization with highly DNA fragmented spermatozoa is still possible (Avendano and Oehninger, 
2011; Zini et al., 2011). 
There is a striking decrease in the live-birth rates following IVF in couples with high sperm DNA 
damage and to a lesser degree after ICSI. Live-birth rates decreased by more than 2-fold, from 
33.3% to 13.1% (Table 3) in IVF patients with high (>50%) sperm DNA fragmentation compared 
with <25% sperm DNA damage. Not surprisingly, the number of ICSI patients with <25% sperm 
DNA damage was very small (only nine out of 136 patients), so the group was too small to 
determine any associations between levels of sperm DNA damage and live-birth rates. However, it 
is worth noting that both pregnancies in this group of patients resulted in live births. In agreement 
with a previous report from this group (Simon et al., 2010), this study observed a shift towards a 
higher level of sperm DNA damage as well as an increase in average sperm DNA fragmentation in 
ICSI patients compared with IVF patients. Since ICSI is a more efficient treatment, in particular 
for patients with higher sperm DNA fragmentation levels, this resulted in slightly greater live-birth 
rates after ICSI compared with IVF for groups with the same levels of sperm DNA damage. A 
strong decline in live-birth rates, from 32.4% to 20.4%, was detected in ISCI patients with 25–
50% sperm DNA damage compared with those with >50% sperm DNA damage. This contradicts 
the finding of Bungum et al. (2007) that delivery rates after ICSI rose from 35.3% to 42.4% for 
patients with DNA fragmentation <30% and >30%, respectively. This may be attributed to a 
different technique used in the study, since the sperm chromatin structure assay measures the 
proportion of spermatozoa with fragmented DNA in the ejaculate rather than DNA damage per 
spermatozoon, as assessed here by the alkaline Comet assay. One question that comes to mind is 
why do spermatozoa with DNA damage not reduce success following ICSI? There are at least four 
hypotheses as to why this is, as discussed below. 
First, up to 30% of women having ICSI have no detectable problems. They may be fertile and 
their oocytes may have more capacity to repair DNA damage even if the injected spermatozoon is 
of poor quality. This is supported by the findings of Meseguer et al. (2011), where high-quality 
oocytes from donors offset the negative impact of sperm DNA damage on pregnancy. Further, the 
study of Devroey et al. (1996) showed that significantly fewer good-quality embryos were 
available for transfer from women older than 40 years compared with the younger group, 
reflecting better DNA repair capacity of oocytes from young women. This is relevant in that 
women undergoing ICSI are often younger than those undergoing IVF as their cause of infertility 
  
has been diagnosed earlier and they have not spent time undergoing failed intrauterine 
insemination or IVF before embarking on a cycle of ICSI. 
Second, in ICSI, the gametes are not subjected to prolonged culture, so the spermatozoa may have 
less damage than those exposed to culture media overnight, as in IVF. The recent major study 
from Dumoulin et al. (2010) shows that even the birthweight of IVF babies can be markedly 
influenced by minor differences in culture conditions. In contrast to IVF, ICSI spermatozoa are 
injected into the optimal environment of the oocyte within a few hours of ejaculation. This may 
protect them from laboratory-induced damage. 
Third, much sperm DNA damage is caused by oxidative stress (Aitken et al.,., 2010) and so these 
spermatozoa are producing reactive oxygen species. If they are used in IVF, the occyte may be 
exposed to oxidative assault during the overnight incubation from these ~0.5 million spermatozoa. 
In ICSI, the oocyte is protected from this attack and can use its energies to repair the damage in 
the spermatozoon immediately following fertilization. 
Fourth, there is now evidence that embryos created from spermatozoa with high DNA damage are 
associated with early pregnancy loss (reviewed by Zini et al., 2008, Robinson et al., 2012) so ICSI 
success rates are sometimes affected adversely by sperm DNA damage, but at a later stage. 
In conclusion, this study found a strong negative association of sperm DNA fragmentation levels 
and live-birth rates in IVF patients. The relationship was more pronounced in patients with 
idiopathic infertility, suggesting that a possible cause of idiopathic infertility might be a high 
degree of sperm DNA fragmentation in such patients. In addition, this study demonstrates an 
importance and feasibility of sperm DNA damage testing to not only assess the treatment 
outcomes in general, but also to specifically evaluate live-birth rates. Lastly, determination of 
sperm DNA fragmentation is highly repeatable and robust. It provides additional information to 
help clinicians to tailor assisted reproduction treatment for men with sperm DNA damage to that 
particular couple’s needs. 
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Table 1. Demographic characteristics of IVF patients. 
Miscarriage No pregnancy Characteristic  Total Idiopathic 
infertility 
Live 
birth Mean 95% CI P-
value 
Mean 95% CI P-value 
No. of cycles 203 70 41 9     153     
Female age (years) 35.6 ± 
0.3 
36.3 ± 0.4 34.5 ± 
0.7 
34.2 ± 1 –3.282 to 2.682 NS 35.9 ± 
0.3 
–2.713 to –
0.08691 
0.04 
Male age (years) 37.1 ± 
0.4 
37.2 ± 0.6 35.5 ± 
0.9 
36.4 ± 
2.1 
–2.760 to 4.560 NS 37.5 ± 
0.4 
–3.647 to –
0.3526 
0.02 
No. of treatments  1.4 ± 0.1 1.3 ± 0.1 1.5 ± 0.1 1.4 ± 0.2 –0.7444 to 
0.5444 
NS 1.4 ± 0.1 –0.2378 to 
0.4378 
NS 
Oocytes fertilized (2 pronucleus)  5.0 ± 0.3 4.9 ± 0.4 6.9 ± 0.6 7.4 ± 1.5 –2.172 to 3.172 NS 4.4 ± 0.3 1.321 to 3.679 < 
0.0001 
Embryos transferred 1.8 ± 
0.04 
1.8 ± 0.1 1.9 ± 
0.04 
2.0 ± 0.0 –0.03529 to 
0.2353 
NS 1.8 ± 
0.05 
–0.05654 to 
0.2565 
NS 
Total embryo cumulative score 13.9 ± 
0.7 
12.6 ± 1.1 14.5 ± 
1.1 
19.3 ± 
3.2 
0.8416 to 8.758 0.02 13.4 ± 
0.9 
–1.316 to 3.516 NS 
Transferred embryo cumulative 
score 
37.8 ± 
1.4 
36.1 ± 2.2 43.0 ± 
2.7 
49.3 ± 
5.7 
–3.714 to 16.31 NS 35.8 ± 
1.7 
1.702 to 12.70 0.01 
Values are mean ± SE unless otherwise stated. 
P-values are for comparison with live births. 
NS = not significant. 
 
  
Table 2. Demographic characteristics of ICSI patients. 
Miscarriage No pregnancy Characteristic 
  
Total Live birth 
Mean 95% CI Mean 95% CI 
No. of cycles 136 34 4  99  
Female age (years) 34.9 ± 0.4 34.5 ± 0.6 35.5 ± 1.7 –3.034 to 5.034 35 ± 0.4 –2.128 to 1.128 
Male age (years) 37.2 ± 0.4 37.5 ± 0.7 38.5 ± 2.7 –3.341 to 5.341 36.9 ± 0.6 –1.128 to 2.328 
No. of treatments  1.7 ± 0.1 1.6 ± 0.1 1.5 ± 0.3 –0.9424 to 0.7424 1.7 ± 0.1 –0.4715 to 0.2715 
Oocytes fertilized (2 pronucleus)  5.3 ± 0.3 6.1 ± 0.6 6.5 ± 1.9 –3.040 to 3.840 4.9 ± 0.3 0.05690 to 2.343a 
Embryos transferred 1.8 ± 0.03 1.9 ± 0.04 2.0 ± 0.0 –0.1054 to 0.3054 1.8 ± 0.0 –0.04035 to 0.2404 
Total embryo cumulative score 13.2 ± 0.9 12.8 ± 1.6 14.9 ± 0.05 –3.754 to 7.954 13.3 ± 1.1 –2.663 to 1.663 
Transferred embryo cumulative score 38.2 ± 2.7 38.8 ± 4.7 48.0 ± 16.0 –9.706 to 28.11 37.1 ± 3.3 –4.759 to 8.159 
Values are mean ± SE unless otherwise stated. 
aP = 0.04 for comparison with live births. 
 
 
  
Table 3. Pregnancy, miscarriage and live-birth rates for men, categorized by 
sperm DNA damage in native semen. 
Tre
atm
ent 
Preg
nanc
ies 
Misc
arria
ges 
Li
ve 
bir
th
s 
<25% sperm 
DNA damage 
25–50% sperm 
DNA damage 
>50% sperm 
DNA damage 
    To
tal 
CP M LB T
ot
al 
CP M LB To
tal 
CP M LB 
IVF 
(n 
= 
203
) 
50 
(24.
6) 
9 
(4.4) 
41 
(2
0.
2) 
33 
(1
6.
3) 
13 
(3
9.
4)a 
2 
(
6.
1
) 
11 
(3
3.
3)b 
7
1 
(
3
5
) 
21 
(2
9.
6)a 
4 
(
5.
6
) 
17 
(2
3.
9)b 
99 
(4
8.
8) 
16 
(1
6.
2)a 
3 
(
3
) 
13 
(1
3.
1)b 
ICS
I (n 
= 
136
) 
38 
(27.
9) 
4 
(2.9) 
34 
(2
5.
0) 
9 
(6
.6
) 
2 
(2
2.
2) 
0 
(
0
) 
2 
(2
2.
2) 
3
4 
(
2
5
) 
13 
(3
8.
2) 
2 
(
5.
9
) 
11 
(3
2.
4) 
93 
(6
8.
4) 
21 
(2
2.
6) 
2 
(
2.
2
) 
19 
(2
0.
4) 
Values are n (%). Sperm DNA fragmentation thresholds as published in Simon et al. (2010, 2011). 
aP-value for pregnancy rate = 0.005. 
bP-value for live-birth rate = 0.007. 
CP = clinical pregnancy rate; ICSI = intracytoplasmic sperm injection; LB = live-birth rate; M = miscarriage rate. 
 
  
Table 4. Sperm DNA fragmentation in men and couples with idiopathic infertility. 
Group with idiopathic 
infertility 
Native semen Prepared 
spermatozoa 
Men (n = 147) 46.9 ± 1.8 32.8 ± 1.6 
Couples (n = 70) 45.8 ± 2.6 32.7 ± 2.4 
Values are mean   SE. 
 
  
Table 5. Outcomes in men and couples with idiopathic infertility, categorized by sperm DNA damage in native semen. 
<25% sperm DNA damage 25–50% sperm DNA damage >50% sperm DNA damage Group with idiopathic 
infertility 
Pregnancies Miscarriages Live 
births Total CP M LB Total CP M LB Total CP M LB 
Men (n = 147) 31 (21.1) 6 (4.1) 25 (17.0) 23 
(15.6) 
6 
(26.1) 
0 
(0) 
6 
(26.1) 
64 
(43.5) 
16 
(25.0) 
4 
(6.3) 
12 
(18.8) 
60 
(40.8) 
9 
(15.0) 
2 
(3.3) 
7 
(11.7) 
Couples (n = 70) 14 (20.0) 4 (5.7) 10 (14.3) 11 
(15.7) 
3 
(27.3) 
0 
(0) 
3 
(27.3) 
32 
(45.7) 
7 (21.9) 3 
(9.4) 
4 (12.5) 27 
(38.6) 
4 
(14.8) 
1 
(3.7) 
3 
(11.1) 
Values are n (%). Sperm DNA fragmentation thresholds as published in Simon et al. (2010, 2011). 
CP = clinical pregnancy rate; LB = live-birth rate; M = miscarriage rate. 
 
  
Figure 1. Sperm DNA damage in patients undergoing IVF or intracytoplasmic sperm injection (ICSI) as assessed by the alkaline Comet assay. Each group was 
compared with the live-birth group and confidence intervals and P-values were calculated for each comparison. Bar = mean ± SE. *P < 0.05; **P < 0.01. 
Figure 2. Normal Q–Q plot of the sperm DNA damage residual. Residuals were plotted for all means. 
  
 
Figure 1. Sperm DNA damage in patients undergoing IVF or ICSI treatment as assessed by the alkaline Comet assay. Each group 
was compared to the “live birth” group and confidence intervals and a P values were calculated for each comparison.  Each bar 
represents means±SE. *P<0.05, **P<0.01. 
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Figure 2. Normal Q_Q plot of the DNA damage residual. Residuals were plotted for all DNA damage means. 
 
 
  
 
 
 
  
Sperm DNA damage has a negative impact on assisted reproduction treatment outcome, in particular, on pregnancy rates. The aim of the present study was to 
examine the relationship between sperm DNA fragmentation and live-birth rates after IVF and intracytoplasmic sperm injection (ICSI). The alkaline Comet assay 
was employed to measure sperm DNA fragmentation in native semen and in spermatozoa following density-gradient centrifugation in semen samples from 203 
couples undergoing IVF and 136 couples undergoing ICSI. Men were divided into groups according to sperm DNA damage and treatment outcome. Following IVF, 
couples with<25% sperm DNA fragmentation had a live birth rate of 33%. In contrast, couples with >50% sperm DNA fragmentation had a much lower live-birth 
rate of 13% following IVF. Following ICSI, there were no significant differences in levels of sperm DNA damage between any groups of patients. Sperm DNA 
damage was also associated with the very low live-birth rates following IVF in both men and couples with idiopathic infertility: 39% of couples and 41% of men 
have high level of sperm DNA damage. Sperm DNA damage assessed by the Comet assay has a close inverse relationship with live-birth rates after IVF. 
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